Читать книгу Secondary Metabolites of Medicinal Plants - Bharat Singh - Страница 63

1 Ahmed, S.A., Ross, S.A., Slade, D. et al. (2008). Cannabinoid ester constituents from high-potency Cannabis sativa. J. Nat. Prod. 71: 536–542.

2 Ahmed, S.A., Ross, S.A., Slade, D. et al. (2015). Minor oxygenated cannabinoids from high potency Cannabis sativa L. Phytochemistry 117: 194–199.

3 Aizpurua-Olaizola, O., Omar, J., Navarro, P. et al. (2014). Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Anal. Bioanal. Chem. 406: 7549–7560.

4 Borgelt, L.M., Franson, K.L., Nussbaum, A.M., and Wang, G.S. (2013). The pharmacologic and clinical effects of medical Cannabis. Pharmacotherapy 33: 195–209.

5 Braemer, R. and Paris, M. (1987). Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L. Plant Cell Rep. 6: 150–152.

6 Brotchie, J.M. (2003). CB1 cannabinoid receptor signalling in Parkinson's disease. Curr. Opin. Pharmacol. 3: 54–61.

7 Choi, Y.H., Kim, H.K., Hazekamp, A. et al. (2004). Metabolomic differentiation of Cannabis sativa cultivars using 1H NMR spectroscopy and principal component analysis. J. Nat. Prod. 67: 953–957.

8 ElSohly, M.A. and Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 78: 539–548.

9 ElSohly, M.A., El-Feraly, F.S., and Turner, C.E. (1977). Isolation and characterization of (+)-cannabitriol and (−)-10-ethoxy-9-hydroxy-D6a(10a)-tetrahydrocannabinol: two new cannabinoids from Cannabis sativa L. extract. Lloydia 40 (3): 275–280.

10 ElSohly, H.N., Boeren, E.G., Turner, C.E., and ElSohly, M.A. (1984). Constituents of Cannabis sativa L. XXIIII: cannabitetrol, a new polyhydroxylated cannabinoid. In: The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects (eds. S. Agurell, W.L. Dewey and R.E. Willette), 89–96. New York: Academic Press.

11 Elzinga, S., Fischedick, J., Podkolinski, R., and Raber, J.C. (2015). Cannabinoids and terpenes as chemotaxonomic markers in Cannabis. Nat. Prod. Chem. Res. 3: 181.

12 Fellermeier, M., Eisenreich, W., Bacher, A., and Zenk, M.H. (2001). Biosynthesis of cannabinoids: incorporation experiments with 13C-labeled glucoses. Eur. J. Biochem. 268: 1596–1604.

13 Fischedick, J., Van Der Kooy, F., and Verpoorte, R. (2010a). Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor. Chem. Pharm. Bull. 58: 201–207.

14 Fischedick, J.T., Hazekamp, A., Erkelens, T. et al. (2010b). Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry 71: 2058–2073.

15 Flores-Sanchez, I.J. and Verpoorte, R. (2008). Secondary metabolism in Cannabis. Phytochem. Rev. 7: 615–639.

16 Flores-Sanchez, I.J., Pčc, J., Fei, J. et al. (2009). Elicitation studies in cell suspension cultures of Cannabis sativa L. J. Biotechnol. 143: 157–168.

17 Formukong, E.A., Evans, A.T., and Evans, F.J. (1988). Analgesic and antiinflammatory activity of constituents of Cannabis sativa L. Inflammation 12: 361–371.

18 Galal, A.M., Slade, D., Gul, W. et al. (2009). Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications. Recent Pat. CNS Drug Discov. 4: 112–136.

19 Giacoppo, S., Mandolino, G., Galuppo, M. et al. (2014). Cannabinoids: new promising agents in the treatment of neurological diseases. Molecules 19: 18781–18816.

20 Grote, H. and Spiteller, G. (1978a). New cannabinoids II. J. Chromatogr. 154: 13–23.

21 Grote, H. and Spiteller, G. (1978b). New cannabinoids. The structure of cannabicoumaronone and analogous compounds. Tetrahedron 34: 3207–3213.

22 Gubellini, P., Picconi, B., Bari, M. et al. (2002). Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J. Neurosci. 22: 6900–6907.

23 Hampson, A.J., Grimaldi, M., Axelrod, J., and Wink, D. (1998). Cannabidiol and (−)D9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. U.S.A. 95: 8268–8273.

24 Hanuš, L.O., Meyer, S.M., Muňoz, E. et al. (2016). Phytocannabinoids: a unified critical inventory. Nat. Prod. Rep. 33: 1357–1392.

25 Happyana, N., Agnolet, S., Muntendam, R. et al. (2013). Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. Phytochemistry 87: 51–59.

26 Hartsel, S.C., Loh, W.H.T., and Robertson, L.W. (1983). Biotransformation of cannabidiol to cannabielsoin by suspension cultures of Cannabis sativa and Saccharum officinarum. Planta Med. 48: 17–19.

27 Hillig, K.W. (2004). A chemotaxonomic analysis of terpenoid variation in Cannabis. Biochem. Syst. Ecol. 32: 875–891.

28 Jiang, H.-E., Li, X., Zhao, Y.-X. et al. (2006). A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai Tombs, Xinjiang, China. J. Ethnopharmacol. 108: 414–422.

29 Johnson, K.A., Conn, P.J., and Niswender, C.M. (2009). Glutamate receptors as therapeutic targets for Parkinson's disease. CNS Neurol. Disord. Drug Targets 8: 475–491.

30 Kajima, M. and Piraux, M. (1982). The biogenesis of cannabinoids in Cannabis sativa. Phytochemistry 21: 67–69.

31 Lewis, M.M., Yang, Y., Wasilewski, E. et al. (2017). Chemical profiling of medical Cannabis extracts. ACS Omega 2: 6091–6103.

32 Li, H.-L. (1973). The origin and use of Cannabis in Eastern Asia: linguistic-cultural implications. Econ. Bot. 28: 293–301.

33 Mackie, K., Devane, W.A., and Hille, B. (1993). Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44: 498–503.

34 Mahlberg, G. and Kim, E.S. (2004). Accumulation of cannabinoids in glandular trichomes of Cannabis (Cannabaceae). J. Ind. Hemp 9: 15–36.

35 Manduca, A., Campolongo, P., and Trezza, V. (2012). Cannabinoid modulation of mother-infant interaction: is it just about milk? Rev. Neurosci. 23: 707–722.

36 Morimoto, S., Komatsu, K., Taura, F., and Shoyama, Y. (1998). Purification and characterization of cannabichromenic acid synthase from Cannabis sativa. Phytochemistry 49: 1525–1529.

37 Morimoto, S., Tanaka, Y., Sasaki, K. et al. (2007). Identification and characterization of cannabinoids that induce cell death through mitochondrial permeability transition in Cannabis leaf cells. J. Biol. Chem. 282: 20739–20751.

38 Nascimento, I.R., Costa, H.B., Souza, L.M. et al. (2015). Chemical identification of cannabinoids in street marijuana samples using electrospray ionization FT-ICR mass spectrometry. Anal. Methods 7: 1415–1424.

39 Pacifico, D., Miselli, F., Carboni, A. et al. (2008). Time course of cannabinoid accumulation and chemotype development during the growth of Cannabis sativa L. Euphytica 160: 231–240.

40 Pate, D.W. (1983). Possible role of ultraviolet radiation in evolution of Cannabis chemotypes. Econ. Bot. 37: 396–405.

41 Pisani, A., Fezza, F., Galati, S. et al. (2005). High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients. Ann. Neurol. 57: 777–779.

42 Pisani, V., Moschella, V., Bari, M. et al. (2010). Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients. Mov. Disord. 25: 920–924.

43 Pisani, V., Madeo, G., Tassone, A. et al. (2011). Homeostatic changes of the endocannabinoid system in Parkinson's disease. Mov. Disord. 26: 216–222.

44 Radwan, M.M., Ross, S., Slade, D. et al. (2008). Isolation and characterization of new Cannabis constituents from a high potency variety. Planta Med. 74: 267–272.

45 Radwan, M.M., Elsohly, M.A., Slade, D. et al. (2009). Biologically active cannabinoids from high-potency Cannabis sativa. J. Nat. Prod. 72: 906–911.

46 Radwan, M.M., ElSohly, M.A., El-Alfy, A.T. et al. (2015). Isolation and pharmacological evaluation of minor cannabinoids from high-potency Cannabis sativa. J. Nat. Prod. 78: 1271–1276.

47 Raharjo, T.J., Eucharia, O., Chang, W.-T., and Verpoorte, R. (2006). Callus induction and phytochemical characterization of Cannabis sativa cell suspension cultures. Indones. J. Chem. 6: 70–74.

48 Ross, S.A. and ElSohly, M.A. (1995). Constituents of Cannabis sativa L. XXVIII. A review of the natural constituents: 1980–1994. Zagazig J. Pharm. Sci 4: 1–10.

49 Ross, S.A., ElSohly, M.A., Sultana, G.N.N. et al. (2005). Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochem. Anal. 16: 45–48.

50 Sato, F. and Kumagai, H. (2013). Microbial production of isoquinoline alkaloids as plant secondary metabolites based on metabolic engineering research. Proc. Jpn. Acad., B, Phys. Biol. Sci. 89: 165–182.

51 Shoyama, Y., Fujita, T., Yamauchi, T., and Nishioka, I. (1968). Cannabichromenic acid, a genuine substance of cannabichromene. Chem. Pharm. Bull. 16: 1157–1158.

52 Srivastava, N.K. and Srivastava, A.K. (2010). Influence of some heavy metals on growth, alkaloid content and composition in Catharanthus roseus L. Indian J. Pharm. Sci. 72: 775–778.

53 Styrczewska, M., Kulma, A., Ratajczak, K. et al. (2012). Cannabinoid-like anti-inflammatory compounds from flax fiber. Cell. Mol. Biol. Lett. 17: 479–499.

54 Tabrez, S., Jabir, N.R., Shakil, S. et al. (2012). A synopsis on the role of tyrosine hydroxylase in Parkinson's disease. CNS Neurol. Disord. Drug Targets 11: 395–409.

55 Takeda, S., Okajima, S., Miyoshi, H. et al. (2012). Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration. Toxicol. Lett. 214: 314–319.

56 Turner, C.E., Mole, M.L., Hanus, L., and ElSohly, H.N. (1981). Constituents of Cannabis sativa. XIX. Isolation and structure elucidation of cannabiglendol, a novel cannabinoid from an Indian variant. J. Nat. Prod. 44: 27–33.

57 Wahby, I., Caba, J.M., and Ligero, F. (2013). Agrobacterium infection of hemp (Cannabis sativa L.): establishment of hairy root cultures. J. Plant Interact. 8: 312–320.

58 Wang, R., He, L.-S., Xia, B. et al. (2009). A micropropagation system for cloning of hemp (Cannabis sativa l.) by shoot tip culture. Pak. J. Bot. 41: 603–608.

59 Whiting, P.F., Wolf, R.F., Deshpande, S. et al. (2015). Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 313: 2456–2473.

60 Yamaguchi, S., Shouji, N., and Kuroda, K. (1995). A new approach to d,l-cannabichromene. Bull. Chem. Soc. Jpn. 68: 305–308.

61 Zhang, W.J. and Björn, L.O. (2009). The effect of ultraviolet radiation on the accumulation of medicinal compounds in plants. Fitoterapia 80: 207–218.